Edwards Lifesciences Corp.'s buy of Cas Medical Systems Inc. (Casmed) this spring appears to have borne fruit. The Irvine, Calif.-based company reported that the U.S. FDA has granted clearance for a smart cable enabling compatibility between the company's Foresight tissue oximetry (brain oxygenation) sensors and the Hemosphere advanced monitoring platform.